Department of Health and Human Services
Public Health Service
5100 Paint Branch Pkwy, HFS-607
From: FDA FLU TASK FORCE-CFSAN
TO: Allera Health Products, Inc. / www.immunextra.com
FROM: Food and Drug Administration
RE: Unapproved/Uncleared/Unauthorized Products Related to the H1N1 Flu Virus
DATE: July 10, 2009
This is to advise you that the United States Food and Drug Administration (FDA) reviewed your website at the Internet address www.immunextra.com on June 26, 2009. The FDA has determined that your website offers a product for sale that is intended to diagnose, mitigate, prevent, treat or cure the H1N1 Flu Virus in people. This product has not been approved, cleared, or otherwise authorized by FDA for use in the diagnosis, mitigation, prevention, treatment, or cure of the H1N1 Flu Virus. This product is Immunextra. The marketing of this product violates the Federal Food, Drug, and Cosmetic Act (FFDC Act) 21 U.S.C. §§ 331, 351, 352. We request that you immediately cease marketing unapproved, uncleared, or unauthorized products for the diagnosis, mitigation, prevention, treatment, or cure of the H1 N1 Flu Virus.
Some examples of the claims on your website include:
- ASK THE DOCTOR ... CAN IMMUNEXTRA BE HELPFUL AGAINST INFLUENZA? YES. The influenze [sic] ("flu") virus first enters cells in your respiratory tract, killing many of your cells as they go.... READ MORE[.]"
- Clicking on the "READ MORE" link quoted above takes visitors to another page on your website, which states, in part, "Ask The Doctor ... Can Immunextra® Be Helpful Against Flu? Any flu that is spreading around the world is a cause for considerable concern. Just like any flu, the H1N1 flu strain first enters cells in your respiratory tract and converts the cells into 'virus factories' that make millions of copies of the flu virus within several hours. ... In most cases, your immune system can help to fight this and eventually clears the virus from your body. Unfortunately, the 'swine' flu virus is a relative stranger to us ... We also recommend taking products that strengthen the immune system, such as Immunextra pinecone extract. Scientists have shown that Immunextra helps build the army of immune cells (dendritic cells) that clear infected cells from the body."
The Secretary of Health and Human Services, under section 319 of the Public Health Service Act, 42 U.S.C. § 247d, has determined that a public health emergency exists nationwide involving the H1 N1 Flu Virus that affects or has the significant potential to affect national security. Following this determination and in response to requests from the U.S. Centers for Disease Control and Prevention, FDA issued letters authorizing the emergency use of certain unapproved and uncleared products or unapproved or uncleared uses of approved or cleared products, provided certain criteria are met, under 21 U.S.C. § 360bbb-3. The marketing and sale of unapproved or uncleared H1N1 Flu Virus-related products that are not authorized by and used in accordance with the conditions of an Emergency Use Authorization, is a potentially significant threat to the public health. Therefore, FDA is taking urgent measures to protect consumers from products that, without approval or authorization by FDA, claim to diagnose, mitigate, prevent, treat or cure H1N1 Flu Virus in people.
You should take immediate action to ensure that your firm is not marketing, and does not market in the future, products intended to diagnose, mitigate, prevent, treat or cure the H1N1 Flu Virus that have not been approved, cleared, or authorized by the FDA. The above is not meant to be an all-inclusive list of violations. It is your responsibility to ensure that the products you market are in compliance with the FFDC Act and FDA's implementing regulations. We advise you to review your websites, product labels, and other labeling and promotional materials to ensure that the claims you make for your products do not adulterate or misbrand the products in violation of the FFDC Act. 21 U.S.C. §§ 331, 351, 352. Within 48 hours. please send an email to FDAFLUTASKFORCECFSAN@fda.hhs.gov. describing the actions that you have taken or plan to take to address your firm's violations. If your firm fails to take corrective action immediately, FDA may take enforcement action, such as seizure or injunction for violations of the FFDC Act without further notice. Firms that fail to take corrective action may also be referred to FDA's Office of Criminal Investigations for possible criminal prosecution for violations of the FFDC Act and other federal laws.
FDA is advising consumers not to purchase or use H1N1 Flu Virus-related products offered for sale that have not been approved, cleared, or authorized by FDA. Your firm will be added to a published list on FDA's website of firms and websites that have received warning letters from FDA concerning marketing unapproved, uncleared, and unauthorized H1N1 Flu Virus-related products in violation of the FFDC Act. This list can be found at www.accessdata.fda.gov/scripts/h1n1flu. Once the violative claims and/or products have been removed from your website, and these corrective actions have been confirmed by the FDA, the published list will be updated to indicate that your firm has taken appropriate corrective action.
If you are not located in the United States, please note that unapproved, uncleared, or unauthorized products intended to diagnose, mitigate, prevent, treat, or cure the H1N1 Flu Virus offered for importation into the United States are subject to detention and refusal of admission. We will advise the appropriate regulatory or law enforcement officials in the country from which you operate that FDA considers your product listed above to be an unapproved, uncleared, or unauthorized product that cannot be legally sold to consumers in the United States.
Please direct any inquiries concerning this letter to FDA at FDAFLUTASKFORCECFSAN@fda.hhs.gov or by contacting Standra Purnell at 301-436-1613.
Office of Compliance
Center for Food Safety and Applied Nutrition
This page was posted on January 31, 2010.